BAY-1316957 is a Selective and Orally Active EP4-R Antagonist
Prostaglandin E2 (PGE2) receptors (EP4-R) are a particularly promising anti-inflammatory and antinociceptive target. Prostaglandin E2 (PGE2) is responsible for inflammatory symptoms. There are at least 4 subtypes of PGE2 receptors,…